| Bioactivity | M2e, human, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A, which is a valid and versatile vaccine candidate to protect against any strain of human influenza A[1]. |
| Name | M2e, human |
| CAS | 251359-24-7 |
| Shortening | SLLTEVETPIRNEWGCRCNDSSD |
| Formula | C107H170N32O41S2 |
| Molar Mass | 2624.81 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. De Filette M, et al. Improved design and intranasal delivery of an M2e-based human influenza A vaccine. Vaccine. 2006 Nov 10;24(44-46):6597-601. |
M2e, human
CAS: 251359-24-7 F: C107H170N32O41S2 W: 2624.81
M2e, human, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.